Proxsys Rx
Proxsys Rx is a Birmingham-based healthcare solutions company that helps U.S. healthcare systems reduce hospital readmissions to deliver long-term cost savings.
- Company typePrivate
- Founded2013
- HeadquartersBirmingham, United States
- Headcount101–250
- GTM typeB2B
- OfferingSoftware
What Proxsys Rx does
Proxsys Rx is a private, for-profit healthcare services company founded in 2013 and headquartered in Birmingham, Alabama. Per its stated company description, it provides healthcare systems with solutions aimed at reducing hospital readmissions, positioning its value proposition around long-term cost savings for its clients rather than around any specific software product, device, or pharmaceutical. The company operates at a mid-stage scale, with headcount in the 101-250 range.
The company's business model appears to be a B2B service offering sold to U.S. healthcare systems, though pricing mechanics — whether the company charges per-bed, per-discharge, on a shared-savings basis tied to CMS Hospital Readmissions Reduction Program penalties, or via subscription — are not disclosed in the available data. The published company description frames the offering in cost-saving terms, which is consistent with either a fee-for-service consulting/delivery model or a value-based / risk-sharing arrangement tied to reduced readmission rates.
Leadership is concentrated in founder George Salem, who serves as Founder & CEO. The company's capital structure includes a 2020 financing led by Fulcrum Equity Partners, a healthcare-focused lower-middle-market private equity firm. Notably, substantive company information — including product detail, technology stack, customer logos, pricing, and revenue — could not be retrieved because the company website (proxsysrx.com) returned a verification challenge rather than content, representing a significant data gap for any deeper diligence.
Proxsys Rx firmographics
Firmographics- Name
- Proxsys Rx
- Website
- https://proxsysrx.com
- Company type
- Private
- Founded year
- 2013
- Headcount range
- 101–250 employees
- Short description
- Proxsys Rx is a Birmingham-based healthcare solutions company that helps U.S. healthcare systems reduce hospital readmissions to deliver long-term cost savings.
- Ownership category
- akta.pro rank
Proxsys Rx industry classification
Industry- Product category
- Hospital Readmission Management
- NAICS
- Computer Systems Design and Related Services (54151)
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- DTx/SaMD Deployment, Integration & Reimbursement Enablement (HLACANAO)
- akta.pro secondary industry
- DTx/SaMD Evidence, Outcomes & Real-World Data (RWE) Platforms (HLACANAM)
Keywords
Where Proxsys Rx is headquartered
LocationHeadquarters
- HQ city
- Birmingham
- HQ country
- United States
- HQ region
- North America
Markets served
Proxsys Rx business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales
Proxsys Rx product offering
Product offeringCore offering
Proxsys Rx is a healthcare solutions company that provides health care systems with long-term cost savings by reducing hospital readmissions. The company delivers post-discharge medication management and care transition services designed to keep patients healthy after they leave the hospital, thereby lowering avoidable readmissions and the associated financial penalties for hospitals.
Differentiator
Problem solved
Functional benefit
Products and services
- Readmission Reduction Program
Companies that use Proxsys Rx
Customer profileIdeal customer profiles1 record
Proxsys Rx technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Proxsys Rx partnerships and signals
Strategic signalRecent moves3 records
Expansion highlights3 records
Proxsys Rx competitors and assessment
Company assessmentDirect peers
- Health Recovery Solutions:
- Tabula Rasa HealthCare: Medication management and pharmacy-led solutions provider targeting health systems and PACE programs to reduce adverse drug events and readmissions. Closely comparable to Proxsys Rx as a pharmacy-services company addressing the same buyer and same readmission KPI.
- CipherHealth: Patient engagement and care transitions platform used by hospitals to reduce readmissions through post-discharge outreach and follow-up. Targets the same health system buyer and readmission KPI as Proxsys Rx.
- Aspen RxHealth: Clinical pharmacist services marketplace delivering medication management to patients post-discharge. Shares the pharmacy-led, health-system-customer, readmission-reduction thesis with Proxsys Rx.
Broad incumbents
- Signify Health: Provides in-home health evaluations and post-acute care services (incorporating Remedy Partners) targeting readmission reduction for payers and providers. Competes with Proxsys Rx for hospital and payer budgets tied to post-discharge management, with broader payer relationships and national reach.
- WellSky: Healthcare IT platform spanning care coordination, post-acute, and hospital software. Competes with Proxsys Rx for hospital budgets allocated to care transitions and readmission reduction, but with much broader product breadth.
- naviHealth (Optum): Post-acute care management platform owned by UnitedHealth/Optum that partners with hospitals and health plans to reduce readmissions. Directly competes with Proxsys Rx for the same health system buyer and the same readmission-reduction outcome, but at significantly greater scale and breadth.
- Collective Medical (PointClickCare): Care coordination and patient event notification platform used by hospitals to manage care transitions and reduce avoidable readmissions. Overlaps with Proxsys Rx for hospital customers and the readmission-reduction use case.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat3 records
Key risks5 records
Key highlights5 records
Customer concentration
Proxsys Rx social profiles
Digital presenceProxsys Rx financial estimates
Financial estimateRevenue estimate
Valuation estimate
Proxsys Rx leadership team
Management profileNumber of profiles
Profiles1 record
Proxsys Rx funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Proxsys Rx M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Proxsys Rx
What does Proxsys Rx do?
Proxsys Rx is a healthcare solutions company that provides health care systems with long-term cost savings by reducing hospital readmissions. The company delivers post-discharge medication management and care transition services designed to keep patients healthy after they leave the hospital, thereby lowering avoidable readmissions and the associated financial penalties for hospitals.
When was Proxsys Rx founded?
Proxsys Rx was founded in 2013. It employs 101 to 250 people.
Where is Proxsys Rx based?
Proxsys Rx is headquartered in Birmingham, United States, in the North America region.
Who are Proxsys Rx's main competitors?
Direct peers on record are Health Recovery Solutions, Tabula Rasa HealthCare, CipherHealth and Aspen RxHealth. Broad incumbents are Signify Health, WellSky, naviHealth (Optum) and Collective Medical (PointClickCare).
Does Proxsys Rx have an API?
No public API is recorded for Proxsys Rx.
What industry is Proxsys Rx in?
Proxsys Rx's product category is Hospital Readmission Management. Its primary akta.pro industry code is HLACANAO, DTx/SaMD Deployment, Integration & Reimbursement Enablement, with a secondary code of HLACANAM, DTx/SaMD Evidence, Outcomes & Real-World Data (RWE) Platforms. Its NAICS code is 54151 and its SIC code is 7372.